ACS-话题@MedSci

#ACS#

407篇内容 | 2253人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1279049, encodeId=b27612e904935, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=JAMA：Aleglitazar不减少2型糖尿病患者ACS后心血管风险, objectType=article, longId=32884, objectId=b7d83288494, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7d83288494, replyNumber=0, likeNumber=87, createdTime=2014-04-06, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7d83288494, moduleTitle=JAMA：Aleglitazar不减少2型糖尿病患者ACS后心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7d83288494)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279048, encodeId=1de812e9048e7, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=ACS Chem Biol：从卫矛属中发现治疗帕金森氏症新化合物, objectType=article, longId=32417, objectId=88213241e61, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88213241e61, replyNumber=0, likeNumber=60, createdTime=2014-03-28, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88213241e61, moduleTitle=ACS Chem Biol：从卫矛属中发现治疗帕金森氏症新化合物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88213241e61)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279047, encodeId=315912e90476b, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=ACS Appl Mater & Inter：科学家研制出新型骨组织仿生支架材料, objectType=article, longId=31973, objectId=f28f319e3c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f28f319e3c8, replyNumber=0, likeNumber=59, createdTime=2014-03-19, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f28f319e3c8, moduleTitle=ACS Appl Mater & Inter：科学家研制出新型骨组织仿生支架材料, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f28f319e3c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279046, encodeId=494b12e9046da, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=全新ACS强化他汀治疗共识, objectType=article, longId=31718, objectId=264331e1810, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=264331e1810, replyNumber=0, likeNumber=65, createdTime=2014-03-12, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=264331e1810, moduleTitle=全新ACS强化他汀治疗共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=264331e1810)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279045, encodeId=1c0012e904545, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=ACS AMI：新型骨修复生物材料, objectType=article, longId=31625, objectId=6ef331625f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ef331625f0, replyNumber=0, likeNumber=66, createdTime=2014-03-09, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ef331625f0, moduleTitle=ACS AMI：新型骨修复生物材料, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ef331625f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279044, encodeId=b1f512e904471, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=Ann Intern Med：基因分型或可改善ACS中双重抗血小板治疗成本效益, objectType=article, longId=30989, objectId=395730989d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=395730989d4, replyNumber=0, likeNumber=69, createdTime=2014-02-23, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=395730989d4, moduleTitle=Ann Intern Med：基因分型或可改善ACS中双重抗血小板治疗成本效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=395730989d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279043, encodeId=beba12e904388, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=JACS：研究发现可诊断良性胰腺囊肿标记物, objectType=article, longId=30872, objectId=8cc7308e239, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cc7308e239, replyNumber=0, likeNumber=72, createdTime=2014-02-21, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cc7308e239, moduleTitle=JACS：研究发现可诊断良性胰腺囊肿标记物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8cc7308e239)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279042, encodeId=846b12e90420d, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=强生拜瑞妥（Xarelto）ACS适应症遭FDA拒绝, objectType=article, longId=30710, objectId=226d30e1046, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=226d30e1046, replyNumber=0, likeNumber=46, createdTime=2014-02-19, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=226d30e1046, moduleTitle=强生拜瑞妥（Xarelto）ACS适应症遭FDA拒绝, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=226d30e1046)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279041, encodeId=763112e9041d9, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=FDA再拒利伐沙班用于ACS, objectType=article, longId=29666, objectId=c1e32966612, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1e32966612, replyNumber=0, likeNumber=64, createdTime=2014-01-22, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1e32966612, moduleTitle=FDA再拒利伐沙班用于ACS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1e32966612)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279040, encodeId=789612e90407a, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=强生拜瑞妥（Xarelto）ACS适应症遭FDA委员会否决, objectType=article, longId=29560, objectId=299929560b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=299929560b7, replyNumber=0, likeNumber=50, createdTime=2014-01-19, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=299929560b7, moduleTitle=强生拜瑞妥（Xarelto）ACS适应症遭FDA委员会否决, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=299929560b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279039, encodeId=603812e903985, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=JAMA：伐瑞拉地不减少ACS患者心血管事件, objectType=article, longId=29516, objectId=225029516a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=225029516a8, replyNumber=0, likeNumber=46, createdTime=2014-01-18, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=225029516a8, moduleTitle=JAMA：伐瑞拉地不减少ACS患者心血管事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=225029516a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279038, encodeId=2c5512e903871, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=FDA对强生拜瑞妥（Xarelto）ACS适应症持谨慎态度, objectType=article, longId=29502, objectId=cad6295023e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cad6295023e, replyNumber=0, likeNumber=70, createdTime=2014-01-18, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cad6295023e, moduleTitle=FDA对强生拜瑞妥（Xarelto）ACS适应症持谨慎态度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cad6295023e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279037, encodeId=539312e90379b, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=ACS Chem Biol：新抑制剂联合用药可显著杀伤结直肠癌细胞, objectType=article, longId=28318, objectId=773e2831854, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=773e2831854, replyNumber=0, likeNumber=57, createdTime=2013-12-21, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=773e2831854, moduleTitle=ACS Chem Biol：新抑制剂联合用药可显著杀伤结直肠癌细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=773e2831854)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279036, encodeId=935d12e903655, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=Heart：冠脉侧枝循环或无益于ACS患者转归, objectType=article, longId=28120, objectId=9fc428120da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fc428120da, replyNumber=0, likeNumber=54, createdTime=2013-12-18, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fc428120da, moduleTitle=Heart：冠脉侧枝循环或无益于ACS患者转归, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fc428120da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279035, encodeId=a36c12e903599, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=ACS患者P2Y12受体拮抗剂的选择, objectType=article, longId=27681, objectId=cffc2e681bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cffc2e681bd, replyNumber=0, likeNumber=65, createdTime=2013-12-08, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cffc2e681bd, moduleTitle=ACS患者P2Y12受体拮抗剂的选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cffc2e681bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279034, encodeId=ea9012e90342f, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=JAMA：sPLA2抑制剂伐瑞拉迪增加ACS后短期内MI风险（VISTA-16研究）, objectType=article, longId=26983, objectId=0b5c2698398, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b5c2698398, replyNumber=0, likeNumber=68, createdTime=2013-11-24, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b5c2698398, moduleTitle=JAMA：sPLA2抑制剂伐瑞拉迪增加ACS后短期内MI风险（VISTA-16研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b5c2698398)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279033, encodeId=353012e9033a7, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=AHA 2013：新的干预方式可改善ACS患者服药依从度, objectType=article, longId=26956, objectId=4fa426956ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fa426956ea, replyNumber=0, likeNumber=62, createdTime=2013-11-24, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fa426956ea, moduleTitle=AHA 2013：新的干预方式可改善ACS患者服药依从度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fa426956ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279032, encodeId=890b12e903288, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=ACS Nano：新纳米粒子可将抗癌药送入细胞, objectType=article, longId=26311, objectId=3d742631100, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d742631100, replyNumber=0, likeNumber=65, createdTime=2013-11-08, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d742631100, moduleTitle=ACS Nano：新纳米粒子可将抗癌药送入细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d742631100)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279031, encodeId=627012e90313a, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=Eur Heart J：ACS患者PCI后双抗治疗6个月以上心肌梗死风险显著降低, objectType=article, longId=26106, objectId=0a7826106be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a7826106be, replyNumber=0, likeNumber=53, createdTime=2013-11-03, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a7826106be, moduleTitle=Eur Heart J：ACS患者PCI后双抗治疗6个月以上心肌梗死风险显著降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a7826106be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1279030, encodeId=63ff12e903018, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=吴永健:替格瑞洛-给中国ACS患者更有力的拯救, objectType=article, longId=25956, objectId=1a112595676, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a112595676, replyNumber=0, likeNumber=70, createdTime=2013-11-01, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a112595676, moduleTitle=吴永健:替格瑞洛-给中国ACS患者更有力的拯救, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a112595676)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ACS

2020-05-29

yaanren (审核中...)

前往app查看评论内容

#ACS#

JAMA：Aleglitazar不减少2型糖尿病患者ACS后心血管风险

2014-04-06

yaanren (审核中...)

前往app查看评论内容

#ACS#

ACS Chem Biol：从卫矛属中发现治疗帕金森氏症新化合物

2014-03-28

yaanren (审核中...)

前往app查看评论内容

#ACS#

ACS Appl Mater & Inter：科学家研制出新型骨组织仿生支架材料

2014-03-19

yaanren (审核中...)

前往app查看评论内容

#ACS#

全新ACS强化他汀治疗共识

2014-03-12

yaanren (审核中...)

前往app查看评论内容

#ACS#

ACS AMI：新型骨修复生物材料

2014-03-09

yaanren (审核中...)

前往app查看评论内容

#ACS#

Ann Intern Med：基因分型或可改善ACS中双重抗血小板治疗成本效益

2014-02-23

yaanren (审核中...)

前往app查看评论内容

#ACS#

JACS：研究发现可诊断良性胰腺囊肿标记物

2014-02-21

yaanren (审核中...)

前往app查看评论内容

#ACS#

强生拜瑞妥（Xarelto）ACS适应症遭FDA拒绝

2014-02-19

heli0118 (审核中...)

前往app查看评论内容

#ACS#

FDA再拒利伐沙班用于ACS

2014-01-22

yaanren (审核中...)

前往app查看评论内容

#ACS#

强生拜瑞妥（Xarelto）ACS适应症遭FDA委员会否决

2014-01-19

yaanren (审核中...)

前往app查看评论内容

#ACS#

JAMA：伐瑞拉地不减少ACS患者心血管事件

2014-01-18

yaanren (审核中...)

前往app查看评论内容

#ACS#

FDA对强生拜瑞妥（Xarelto）ACS适应症持谨慎态度

2014-01-18

yaanren (审核中...)

前往app查看评论内容

#ACS#

ACS Chem Biol：新抑制剂联合用药可显著杀伤结直肠癌细胞

2013-12-21

yaanren (审核中...)

前往app查看评论内容

#ACS#

Heart：冠脉侧枝循环或无益于ACS患者转归

2013-12-18

yaanren (审核中...)

前往app查看评论内容

#ACS#

ACS患者P2Y12受体拮抗剂的选择

2013-12-08

yaanren (审核中...)

前往app查看评论内容

#ACS#

JAMA：sPLA2抑制剂伐瑞拉迪增加ACS后短期内MI风险（VISTA-16研究）

2013-11-24

yaanren (审核中...)

前往app查看评论内容

#ACS#

AHA 2013：新的干预方式可改善ACS患者服药依从度

2013-11-24

yaanren (审核中...)

前往app查看评论内容

#ACS#

ACS Nano：新纳米粒子可将抗癌药送入细胞

2013-11-08

yaanren (审核中...)

前往app查看评论内容

#ACS#

Eur Heart J：ACS患者PCI后双抗治疗6个月以上心肌梗死风险显著降低

2013-11-03

yaanren (审核中...)

前往app查看评论内容

#ACS#

吴永健:替格瑞洛-给中国ACS患者更有力的拯救

2013-11-01

科室
- - 订阅+
  - 更多科室
工具
服务